109 related articles for article (PubMed ID: 15646703)
1. Pharmaceutical manufacturers' compliance with drug advertisement regulations in Zimbabwe.
Sibanda N; Gavaza P; Maponga CC; Mugore L
Am J Health Syst Pharm; 2004 Dec; 61(24):2678-81. PubMed ID: 15646703
[No Abstract] [Full Text] [Related]
2. UK watchdog investigates promotional children's book.
Pincock S
Lancet; 2003 Aug; 362(9384):625. PubMed ID: 12947945
[No Abstract] [Full Text] [Related]
3. [On ethical issues of pharmaceutical communication. National Association of Hungarian Pharmaceutical Manufacturers and Wholesalers].
Kata M; Sánta Z
Orv Hetil; 1994 Oct; 135(42):2343-7. PubMed ID: 7970650
[No Abstract] [Full Text] [Related]
4. Legislative and non-legislative regulations concerning Rx drug advertisement in the European Union and the United States--comparative analysis.
Czerw A; Religioni U
Acta Pol Pharm; 2012; 69(4):779-87. PubMed ID: 22876622
[TBL] [Abstract][Full Text] [Related]
5. Restrictions on the conduct of advertising of medicinal products in Poland and their violations.
Czerw A; Marek EM
Acta Pol Pharm; 2013; 70(4):769-76. PubMed ID: 23923402
[TBL] [Abstract][Full Text] [Related]
6. Drug company accused of breaking advertising regulations.
Waechter F
BMJ; 2003 May; 326(7399):1106. PubMed ID: 12763970
[No Abstract] [Full Text] [Related]
7. Regulating pharmaceutical advertising: what will work?
Shapiro MF
CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
[TBL] [Abstract][Full Text] [Related]
8. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
[No Abstract] [Full Text] [Related]
9. [Drug advertising and promotion: regulations and extent of compliance in five Latin American countries].
Vacca C; Vargas C; Cañás M; Reveiz L
Rev Panam Salud Publica; 2011 Feb; 29(2):76-83. PubMed ID: 21437364
[TBL] [Abstract][Full Text] [Related]
10. Compliance with indoor tanning advertising regulations in France.
De Maleissye MF; Fay-Chatelard F; Beauchet A; Saiag P; Mahé E
Br J Dermatol; 2011 Apr; 164(4):880-2. PubMed ID: 21434878
[No Abstract] [Full Text] [Related]
11. Drug marketing in the Third World.
Hosking G
Lancet; 1986 Jul; 2(8499):164. PubMed ID: 2873426
[No Abstract] [Full Text] [Related]
12. Ensuring ethical drug promotion--whose responsibility?
Quick JD; Hogerzeil HV; Rägo L; Reggi V; de Joncheere K
Lancet; 2003 Aug; 362(9385):747. PubMed ID: 12957107
[No Abstract] [Full Text] [Related]
13. Drug companies' evidence to justify advertising.
Wade VA; Mansfield PR; McDonald PJ
Lancet; 1989 Nov; 2(8674):1261-3. PubMed ID: 2573769
[TBL] [Abstract][Full Text] [Related]
14. Drug firms vow to tone down consumer advertisements.
Wadman M
Nat Med; 2005 Sep; 11(9):910. PubMed ID: 16145559
[No Abstract] [Full Text] [Related]
15. FDA considers tightening regulations for direct-to-consumer advertising.
Vastag B
J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
[No Abstract] [Full Text] [Related]
16. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
Schwartz MI
Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
[No Abstract] [Full Text] [Related]
17. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
Desjardins JG
CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
[TBL] [Abstract][Full Text] [Related]
18. AstraZeneca reprimanded for nolvadex advertisement.
Fintor L
J Natl Cancer Inst; 2002 Mar; 94(5):330. PubMed ID: 11880471
[No Abstract] [Full Text] [Related]
19. Pharmaceutical advertising: from prospectus to marketing.
Cambronero-Saiz B
J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300
[No Abstract] [Full Text] [Related]
20. Drug advertising.
Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
